ecteinascidin 743 has been researched along with Anemia, Fanconi in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albella, B; Aracil, M; Bueren, JA; Gago, F; Galmarini, CM; Martínez, S; Pérez, L; Tercero, JC | 1 |
Albella, B; Bueren, JA; Casado, JA; Domingo, A; Gago, F; García-Hernández, V; Marco, E; Pérez, L; Río, P; Tercero, JC; Vaquero, JJ | 1 |
2 other study(ies) available for ecteinascidin 743 and Anemia, Fanconi
Article | Year |
---|---|
Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway.
Topics: Animals; Antineoplastic Agents; Binding Sites; Carbolines; Cell Line, Tumor; Dioxoles; DNA; Dose-Response Relationship, Drug; Fanconi Anemia; Fanconi Anemia Complementation Group Proteins; Hematopoietic Stem Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Transgenic; Mitomycin; Neoplasms; Signal Transduction; Tetrahydroisoquinolines; Trabectedin | 2013 |
Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin.
Topics: Antineoplastic Agents, Alkylating; Cell Cycle; Dioxoles; DNA; DNA Breaks, Double-Stranded; DNA Repair; Dose-Response Relationship, Drug; Fanconi Anemia; Fanconi Anemia Complementation Group Proteins; Humans; Mitomycin; Tetrahydroisoquinolines; Time Factors; Trabectedin | 2008 |